PharmaShots | Incisive News in 3 Shots

Subscribe Now

mRNA-1273

Moderna's mRNA-1273 Demonstrates 94.5% Efficacy in Preventing Symptomatic COVID-19

Moderna's mRNA-1273 Demonstrates 94.5% Efficacy in Preventing Symptomatic COVID-19

November 17, 2020

Moderna Initiates Rolling Submission to Health Canada for mRNA-1273 Against COVID-19

Moderna Initiates Rolling Submission to Health Canada for mRNA-1273 Against COVID-19

October 14, 2020

Moderna's mRNA-1273 COVID-19 Vaccine Demonstrate Immune Responses in Older Adults

Moderna's mRNA-1273 COVID-19 Vaccine Demonstrate Immune Responses in Older Adults

October 1, 2020

BARDA Grants ~ $483M to Moderna for Accelerating the Development of mRNA-1273 Against COVID-19

BARDA Grants ~ $483M to Moderna for Accelerating the Development of mRNA-1273 Against COVID-19

April 17, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us